| Development of risperidone liposomes for brain targeting through intranasal route R Narayan, M Singh, OP Ranjan, Y Nayak, S Garg, GV Shavi, UY Nayak Life sciences 163, 38-45, 2016 | 121 | 2016 |
| Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoids MK Unnikrishnan, V Veerapur, Y Nayak, PP Mudgal, G Mathew Polyphenols in human health and disease, 143-161, 2014 | 115* | 2014 |
| Design and synthesis of 2-quinolones as antioxidants and antimicrobials: a rational approach BS Jayashree, S Thomas, Y Nayak Medicinal chemistry research 19, 193-209, 2010 | 94 | 2010 |
| Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system UY Nayak, GV Shavi, Y Nayak, RK Averinen, S Mutalik, SM Reddy, ... Journal of Controlled Release 136 (2), 125-131, 2009 | 77 | 2009 |
| Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy R Narayan, S Gadag, SP Cheruku, AM Raichur, CM Day, S Garg, ... Carbohydrate Polymers 261, 117893, 2021 | 73 | 2021 |
| Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy S Gadag, R Narayan, AS Nayak, DC Ardila, S Sant, Y Nayak, S Garg, ... International journal of pharmaceutics 606, 120877, 2021 | 64 | 2021 |
| Targeting SARS-CoV-2 main protease: a computational drug repurposing study K Baby, S Maity, CH Mehta, A Suresh, UY Nayak, Y Nayak Archives of medical research 52 (1), 38-47, 2021 | 63 | 2021 |
| Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19 K Baby, S Maity, CH Mehta, A Suresh, UY Nayak, Y Nayak F1000Research 9, 2020 | 62 | 2020 |
| Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance S Maity, KSR Pai, Y Nayak Pharmacological Reports 72, 799-813, 2020 | 58 | 2020 |
| Radioprotective effect of Ocimum sanctum and amifostine on the salivary gland of rats after therapeutic radioiodine exposure LJ Joseph, US Bhartiya, YS Raut, RW Hawaldar, Y Nayak, YP Pawar, ... Cancer Biotherapy and Radiopharmaceuticals 26 (6), 737-743, 2011 | 58 | 2011 |
| Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives NB Fernandes, Y Nayak, S Garg, UY Nayak Coordination Chemistry Reviews 478, 214977, 2023 | 54 | 2023 |
| Development of ritonavir solid lipid nanoparticles by Box Behnken design for intestinal lymphatic targeting S Kumar, R Narayan, V Ahammed, Y Nayak, A Naha, UY Nayak Journal of Drug Delivery Science and Technology 44, 181-189, 2018 | 52 | 2018 |
| Antidiabetic activity of benzopyrone analogues in nicotinamide‐streptozotocin induced type 2 diabetes in rats Y Nayak, V Hillemane, VK Daroji, BS Jayashree, MK Unnikrishnan The Scientific World Journal 2014 (1), 854267, 2014 | 52 | 2014 |
| Hybrid nanostructures: Versatile systems for biomedical applications S Mehta, A Suresh, Y Nayak, R Narayan, UY Nayak Coordination Chemistry Reviews 460, 214482, 2022 | 48 | 2022 |
| SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study K Baby, S Maity, CH Mehta, A Suresh, UY Nayak, Y Nayak European Journal of Pharmacology 896, 173922, 2021 | 45 | 2021 |
| Evaluation of the antioxidant activity of novel synthetic chalcones and flavonols H Venkatachalam, Y Nayak, BS Jayashree International Journal of Chemical Engineering and Applications 3 (3), 216, 2012 | 44 | 2012 |
| Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting V Ahammed, R Narayan, J Paul, Y Nayak, B Roy, GV Shavi, UY Nayak Life sciences 183, 11-20, 2017 | 35 | 2017 |
| Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis V Velagacherla, CH Mehta, Y Nayak, UY Nayak Life Sciences 291, 120283, 2022 | 34 | 2022 |
| Combination therapy and nanoparticulate systems: smart approaches for the effective treatment of breast cancer S Gadag, S Sinha, Y Nayak, S Garg, UY Nayak Pharmaceutics 12 (6), 524, 2020 | 32 | 2020 |
| Synthesis, characterization and antioxidant activities of synthetic chalcones and flavones H Venkatachalam, Y Nayak, BS Jayashree Apcbee Procedia 3, 209-213, 2012 | 32 | 2012 |
Usha Y NayakProfessor of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher確認したメール アドレス: manipal.edu